SecBot SecBot
8-K ·Filed Oct 15, 2026

EVFM

Evofem Biosciences, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed11d 14h ago SEC0001493152-26-047227
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

Monitor for any change-of-control event or acceleration that could trigger early repayment. The December 1, 2026 maturity date is now the key deadline for the notes.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
EVFM ▼ -14.29% at T+5d
NEUTRAL call -14.29% · α vs SPY -14.38% · entry $0.007000 → $0.006000
Next anchor: T+20d in 16d
Entry = T+0 close
Oct 15, 2026
via day close
T+1d
-14.29%
call -14.29% · α -14.71%
$0.006000
settled 11d ago
T+5d
-14.29%
call -14.29% · α -14.38%
$0.006000
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Evofem Biosciences entered into a fifth amendment to its securities purchase agreement with Adjuvant, extending the maturity date of convertible promissory notes to December 1, 2026, and removing certain affirmative covenants. This is a routine debt extension with no new financing or material change in terms.

Key Facts

  • Fifth amendment to Securities Purchase Agreement dated October 9, 2026.
  • Maturity date extended to the earlier of December 1, 2026, change of control, or acceleration.
  • Notes may not be prepaid before December 1, 2026 without Adjuvant's consent.
  • Certain affirmative covenants under Section 7.1 of the SPA were removed.

Financial Impact

No new financing or dollar amounts disclosed; existing convertible notes extended to December 1, 2026.

debt_maturity

Risk Factors

  • No new capital raised — existing debt simply extended.
  • Removal of affirmative covenants reduces creditor protections.

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-047227
Exhibit: ex10-1.htm0001493152-26-047227
Document: 0001493152-26-047227-index-headers.html0001493152-26-047227
Document: 0001493152-26-047227-index.html0001493152-26-047227
Document: 0001493152-26-047227.txt0001493152-26-047227
4 reports for EVFM
Performance horizon
Filters
Rows
Reports for EVFM — sortable, filterable
TypeNow
Oct 15, 2026
11d ago
8-K
NEUTRAL ★ 3/10
$0.007000awaiting T+20—$0.007000 (+0.00%)
May 18, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$0.007000 $0.007000· 0.00%▼ −1.58%$0.007000 (+0.00%)
Apr 30, 2026
25w ago
8-K
NEUTRAL ★ 4/10
$0.007000 $0.007000· 0.00%▼ −5.27%$0.007000 (+0.00%)
Mar 11, 2026
32w ago
8-K
NEUTRAL ★ 4/10
$0.009000 $0.009000· 0.00%▼ −1.98%$0.007000 (−22.22%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 3h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 15, 2026